Drug Discovery Artificial Intelligence Articles & Analysis
7 news found
Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Agnieszka Blum, MD, PhD has joined the company’s Board of Management. She brings with her extensive knowledge and experience in the field of Immuno-Oncology and drug discovery, which is ...
ByArdigen
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today that its Founder and Chief Executive Officer, Brendan Frey, Ph.D., F.R.S.C., will participate in a panel discussion during the Citi PCA – Private Company Digital Health Conference *VIRTUAL* on May 20, 2021. Details: Session: Artificial ...
Date: Thursday, February 3, 2022 Time: 2pm ET / 11am PT Duration: 1 Hour Sign up here to go to the webinar Improving the discovery of novel drugs with artificial intelligence Last year, Toronto-based Deep Genomics used artificial intelligence to scan 200,000 genomes from people with ...
Computer-aided drug design (CADD) has penetrated into all aspects of drug discovery. With the in-depth application of artificial intelligence and cloud computing, it can be anticipated that CADD will play a role in drug discovery projects in the future, improving efficiency and ...
(known as MSD outside of the United States and Canada) to evaluate the combination of Evaxion’s cancer immunotherapy EVX-01 with MSD’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in a new Phase 2b clinical trial in patients with metastatic melanoma Awarded this year’s Enabling Technology Leadership Award in the artificial ...
(Nasdaq: BMRN) and Deep Genomics today announced that the companies have entered into a preclinical collaboration that will use Deep Genomics’ artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications with high unmet need. ...
The Medical Innovation Summit, which is celebrating its 17th year, is covering a wide range of topics including artificial intelligence, new drug discovery, advanced diagnostics development, and the personalization of healthcare. ...